A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

This study confirmed that both venlafaxine XR and trazodone OAD may represent a valid treatment option for patients with MDD.
Source: International Clinical Psychopharmacology - Category: Psychiatry Tags: Original Articles Source Type: research